<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Anatara_Lifesciences_Limited</id>
	<title>Anatara Lifesciences Limited - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Anatara_Lifesciences_Limited"/>
	<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Anatara_Lifesciences_Limited&amp;action=history"/>
	<updated>2026-05-26T01:38:47Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.5</generator>
	<entry>
		<id>https://stockhub.co/index.php?title=Anatara_Lifesciences_Limited&amp;diff=54269&amp;oldid=prev</id>
		<title>&gt;Paris: Created page with &quot;== Summary&lt;ref&gt;Source: Yahoo Finance.&lt;/ref&gt; ==  Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome (...&quot;</title>
		<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Anatara_Lifesciences_Limited&amp;diff=54269&amp;oldid=prev"/>
		<updated>2022-08-18T10:52:07Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==  Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome (...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD); and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets. In addition, it is developing bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.&lt;br /&gt;
&lt;br /&gt;
== References and notes == &lt;br /&gt;
[[Category:Thesis]]&lt;br /&gt;
__INDEX__&lt;/div&gt;</summary>
		<author><name>&gt;Paris</name></author>
	</entry>
</feed>